跳至主要内容
临床试验/NCT06878638
NCT06878638已完成不适用

Impact of Intravenous Nitrate Treatment on Antiplatelet Effects of Clopidogrel in Acute Coronary Syndrome Patients: A Pilot Study

Bursa Postgraduate Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Platelet Reactivity Unit level

研究概览

简要总结

This study aims to investigate whether intravenous nitrate given during non-ST-elevation myocardial infarction (non-STEMI) affects the platelet inhibition of clopidogrel.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •diagnosed with non-STEMI
  • •Patients aged 18 to 75 years
  • •positive troponin levels,
  • •blood pressure above 120/70 mmHg

排除标准

  • •Hemodynamically unstable and requiring urgent intervention,
  • •ST elevation on electrocardiography, atrial fibrillation,
  • •recurrent angina,
  • •use of narcotic analgesics (e.g., morphine), nitrates and glycoprotein IIb/IIIa inhibitors during hospitalization,
  • •history of coronary artery bypass graft (CABG) surgery,
  • •active infection,
  • •uncontrolled hypertension,
  • •diabetes, cerebrovascular accident, Use P2Y12 inhibitor, proton pump inhibitor, oral anticoagulant, statin, CYP enzyme-inducing or inhibiting drugs at the time of admission,
  • •active systemic disease (e.g., malignancy, thyroid disorders chronic inflammatory diseases, liver dysfunction),
  • •left ventricular systolic dysfunction (ejection fraction <50%),
  • •glomerular filtration rate <60 mL/min/1.73m2,
  • •allergy to ASA or clopidogrel, coagulopathy,
  • •platelet counts below 100,000/μl and hematocrit levels below 29%, or exceeding 52%.

结局指标

主要结局

Platelet Reactivity Unit level

时间窗: 48 hours

Platelet Reactivity Unit \<208

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hasan ARI

Professor Doctor

Bursa Postgraduate Hospital

研究点 (1)

Loading locations...

相似试验